[{"id":"f97ed4c8-45f9-4ad2-bbda-38783a88ec51","acronym":"ADG106-1002","url":"https://clinicaltrials.gov/study/NCT03802955","created_at":"2021-01-18T18:47:54.788Z","updated_at":"2024-07-02T16:35:49.791Z","phase":"Phase 1","brief_title":"Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma","source_id_and_acronym":"NCT03802955 - ADG106-1002","lead_sponsor":"Adagene (Suzhou) Limited","biomarkers":" IL6 • IL2 • IL10 • IL4","pipe":"","alterations":" ","tags":["IL6 • IL2 • IL10 • IL4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ADG106"],"overall_status":"Completed","enrollment":" Enrollment 62","initiation":"Initiation: 12/20/2018","start_date":" 12/20/2018","primary_txt":" Primary completion: 11/01/2021","primary_completion_date":" 11/01/2021","study_txt":" Completion: 11/01/2021","study_completion_date":" 11/01/2021","last_update_posted":"2023-04-24"}]